Financial modeling

The deal model, out of the spreadsheet

Every BD shop has the workbook — the one person who maintains it, the version nobody's sure is current. PharmaDealFlow puts license and royalty modeling in the platform: interactive, scenario-driven, attached to the deal, and rendered board-ready on demand.

Product-level models you can argue with

  • License & royalty forecasting per product — market size, share curves, pricing, royalty tiers, and milestones, all adjustable live.
  • Scenario overrides: change an assumption, watch the model reprice; save and reload scenarios by name.
  • Batch mode across a portfolio — model twenty products in one pass, with a dashboard across the set and a combined PDF.
  • Seeded from real sales data you load, not hand-typed guesses.
Forecast — Product A · base case
Y1Y2Y3Y4Y5Y6

scenario "Conservative uptake" saved · peak share 11%

export combined portfolio PDF — 14 products

Revenue — royalties & milestones
Q3 profit share — Product Areceived
Launch milestone — Product Cdue Q1
Recoupment balance — Product Dtracking

gated financial pages visible to finance-cleared roles only

invoice generated and sent from the platform

Then track the money that actually arrives

  • Royalty and profit-share tracking per product, quarter by quarter, with milestones and recoupment handled properly.
  • Forecast vs. actual in one place — the model and the receipts live on the same product record.
  • Financial data is role-gated down to the database row — commercial users see the pipeline, not the economics.
  • Invoicing built in: branded invoices generated, numbered, and sent per business entity.

Keep exploring

The rest of the platform